Abstract
The cost-effectiveness of infliximab (Remicade) in the treatment of ankylosing spondylitis in Canada.
Gisela Kobelt, Patrik Andlin-Sobocki and Walter P Maksymowych
The Journal of Rheumatology April 2006, 33 (4) 732-740;
Gisela Kobelt
Patrik Andlin-Sobocki
In this issue
The Journal of Rheumatology
Vol. 33, Issue 4
1 Apr 2006
The cost-effectiveness of infliximab (Remicade) in the treatment of ankylosing spondylitis in Canada.
Gisela Kobelt, Patrik Andlin-Sobocki, Walter P Maksymowych
The Journal of Rheumatology Apr 2006, 33 (4) 732-740;